These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 15324602)
21. Estrogen: effects on normal brain function and neuropsychiatric disorders. Craig MC; Murphy DG Climacteric; 2007 Oct; 10 Suppl 2():97-104. PubMed ID: 17882683 [TBL] [Abstract][Full Text] [Related]
22. Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. Henderson VW J Steroid Biochem Mol Biol; 2014 Jul; 142():99-106. PubMed ID: 23727128 [TBL] [Abstract][Full Text] [Related]
23. Action of estrogens in the aging brain: dementia and cognitive aging. Henderson VW Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598 [TBL] [Abstract][Full Text] [Related]
24. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? Birge SJ J Am Geriatr Soc; 1996 Jul; 44(7):865-70. PubMed ID: 8675940 [TBL] [Abstract][Full Text] [Related]
25. The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers. Miller KJ Curr Psychiatry Rep; 2003 Dec; 5(6):439-44. PubMed ID: 14609498 [TBL] [Abstract][Full Text] [Related]
27. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Yaffe K; Krueger K; Cummings SR; Blackwell T; Henderson VW; Sarkar S; Ensrud K; Grady D Am J Psychiatry; 2005 Apr; 162(4):683-90. PubMed ID: 15800139 [TBL] [Abstract][Full Text] [Related]
28. Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease? Mills ZB; Faull RLM; Kwakowsky A Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834617 [TBL] [Abstract][Full Text] [Related]
29. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Green PS; Simpkins JW Ann N Y Acad Sci; 2000; 924():93-8. PubMed ID: 11193809 [TBL] [Abstract][Full Text] [Related]
30. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Greene RA Int J Fertil Womens Med; 2000; 45(4):253-7. PubMed ID: 10997480 [TBL] [Abstract][Full Text] [Related]
31. Pharmacologic approaches to cognitive deficits in Alzheimer's disease. Peskind ER J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483 [TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy and Alzheimer's disease. van Duijn CM Maturitas; 1999 Mar; 31(3):201-5. PubMed ID: 10340279 [TBL] [Abstract][Full Text] [Related]
33. Antioxidants for the treatment of mild cognitive impairment. Mecocci P; Mariani E; Cornacchiola V; Polidori MC Neurol Res; 2004 Jul; 26(5):598-602. PubMed ID: 15265281 [TBL] [Abstract][Full Text] [Related]
34. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Hogervorst E; Williams J; Budge M; Riedel W; Jolles J Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299 [TBL] [Abstract][Full Text] [Related]
35. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Simpkins JW; Singh M; Bishop J Neurobiol Aging; 1994; 15 Suppl 2():S195-7. PubMed ID: 7700453 [No Abstract] [Full Text] [Related]
36. Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. Fillenbaum GG; Hanlon JT; Landerman LR; Schmader KE Am J Epidemiol; 2001 Jan; 153(2):137-44. PubMed ID: 11159158 [TBL] [Abstract][Full Text] [Related]
37. Preventing Alzheimer disease and cognitive decline. Naftolin F; Harman SM Ann Intern Med; 2011 Feb; 154(3):211-2; author reply 212-3. PubMed ID: 21282704 [No Abstract] [Full Text] [Related]